{"id":"W3178688808","doi":"10.1158/1538-7445.am2021-1066","title":"Abstract 1066: Pre-clinical combination of a PARP inhibitor, talazoparib, and carboplatin in triple-negative breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Carboplatin; Triple-negative breast cancer; PARP inhibitor; Medicine; Breast cancer; Cancer research; Cancer; Combination therapy; Internal medicine; Oncology; Chemotherapy; Poly ADP ribose polymerase; Biology; Cisplatin; DNA","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003208567,0.0004250588,0.0008657867,0.0003377124,0.0002051602,0.0004338589,0.0003594408,0.0003153022,0.002607495],"category_scores_gemma":[0.0002486109,0.0001635718,0.0002909523,0.0003119718,0.0002005526,0.000234942,0.000228379,0.0009675459,0.0005334576],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006261241,"about_ca_system_score_gemma":0.0005616241,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00140964,"about_ca_topic_score_gemma":0.004046284,"domain_scores_codex":[0.9998317,0.00003305607,0.00001648905,0.00002904208,0.00004873528,0.00004105093],"domain_scores_gemma":[0.9998885,0.00001523233,0.00001402454,0.00000995456,0.00001601951,0.0000562596],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.03265868,0.009623542,0.01171802,0.000870384,0.000437667,0.001100364,0.0001660954,0.002328153,0.8033835,0.0002192851,0.005451944,0.1320423],"study_design_scores_gemma":[0.008196397,0.1225786,0.09254367,0.0001105366,0.0008525647,0.005419518,0.00019443,0.005614151,0.7386783,0.0001538683,0.02559426,0.00006370281],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9889544,0.005528402,0.0006980241,0.0003110193,0.00009904399,0.0003040986,0.0004523433,0.0001364059,0.003516221],"genre_scores_gemma":[0.994758,0.001298005,0.001262154,0.000116586,0.00003208538,0.00009951382,0.0008333728,0.00001949403,0.001580739],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002607495,"threshold_uncertainty_score":0.008722961,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1176806995172702,"score_gpt":0.4877386973206827,"score_spread":0.3700579978034125,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}